Search Orphan Drug Designations and Approvals
-
Generic Name: | A potent and selective inhibitor of Gamma Secretase-mediated NOTCH signaling |
---|---|
Date Designated: | 05/08/2019 |
Orphan Designation: | Treatment of Adenoid cystic carcinoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Ayala Pharmaceuticals, Inc. 7 Oppenheimer St., Rehovot Israel The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-